News

18 September 2019
Baylis Medical announced today key activities that will be featured at Transcatheter Cardiovascular Therapeutics (TCT) 2019, the Cardiovascular Research Foundation’s 31st annual conference and premier interventional cardiovascular medicine educational meeting, in San Francisco, CA from September 25-29.
Press Release
19 June 2019
A cost-effectiveness analysis completed by the University of California, San Francisco (UCSF) and Baylis Medical has shown that use of Baylis’ RF transseptal needle results in cost savings per procedure, compared to use of a mechanical transseptal needle.
Press Release
07 March 2019
For the second year in a row, Baylis Medical has won the Canada’s Best Managed Companies designation.
Press Release
30 January 2019
Baylis Medical is pleased to announce that seasoned marketing executive Gloria Yee has joined Baylis as its Vice President of Marketing. In her role, Gloria will be instrumental in expanding the company’s global commercialization strategy.
Press Release
23 January 2019
Baylis Medical announced today the Canadian launch and first clinical use of its ExpanSure™ Transseptal Dilation System. The device combines a sheath and dilator into a single tool, and facilitates larger dilation compared to a standard fixed curve sheath.
Press Release
24 September 2018
Baylis Medical is partnering with the University of Waterloo Engineering program to establish the Gloria Baylis Entrance Award, in support of the learning and development of new engineering students.
Press Release

Media Contact

media@baylismedical.com